Syndax Pharmaceuticals
SNDX
SNDX
72 hedge funds and large institutions have $146M invested in Syndax Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 21 increasing their positions, 21 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 21
1.72% less ownership
Funds ownership: 63.16% → 61.44% (-1.7%)
Holders
72
Holding in Top 10
1
Calls
$3.6M
Puts
$1.23M
Top Buyers
| 1 | +$559K | |
| 2 | +$394K | |
| 3 | +$358K | |
| 4 |
Goldman Sachs
New York
|
+$345K |
| 5 |
Two Sigma Investments
New York
|
+$337K |
Top Sellers
| 1 | -$2.17M | |
| 2 | -$1.82M | |
| 3 | -$1.32M | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$691K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$525K |